SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership
The companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland, April
Read MoreThe companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland, April
Read MoreNew Multimodal Algorithm Highlights Predictive Benefit Of Artificial Intelligence (AI) for Cancer Research BOSTON and ROLLE, Switzerland, March 15, 2024
Read MoreSOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain BOSTON and
Read MoreSOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge genomic
Read MoreThe SOPHiA DDM™ Platform used by IHG PAS to advance its research of male infertility BOSTON and ROLLE, Switzerland, Nov.
Read MoreThe three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science
Read MoreHuman and Machine collaborate via monumental AR NFT to reimagine climate crisis solutions on Algorand MIAMI and DUBAI, UAE, Nov.
Read MorePISCATAWAY, N.J., Sept. 22, 2022 /PRNewswire/ — IEEE, the world’s largest technical professional organization dedicated to advancing technology for the
Read MoreBOSTON and LAUSANNE, Switzerland, June 15, 2022 /PRNewswire/ — SOPHiA GENETICS SA (Nasdaq: SOPH) (“the Company“), is pleased to announce
Read MoreBOSTON and LAUSANNE, Switzerland, May 5, 2022 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, today announced the nomination
Read More